Related Experiment Videos
Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines
H Burger1, K Nooter, A W Boersma
1Department of Medical Oncology, University Hospital Rotterdam, Josephine Nefkens Institute, The Netherlands.
Abstract:
The induction of apoptosis by diverse apoptotic stimuli was studied in a panel of 6 testicular germ cell tumour (TGCT) cell lines with defined p53 status. Although the sensitivity to a particular stimulus varied considerably among the TGCT cell lines, the differences in response were not associated with the presence of functional p53. Mutant (mt) p53-expressing NCCIT and S2 (no p53 protein) were both readily triggered into apoptosis by cisplatin and doxorubicin, while wild-type(wt)-p53-transactivation-competent 2102 EP cells failed to undergo drug-induced apoptosis. Moreover, transactivation-deficient NCCIT cells and wtp53-expressing NT2 cells were equally sensitive to cisplatin, doxorubicin, gamma radiation, and cell-permeable C2-ceramide. Our p53 data suggest that, at least in this panel of non-isogeneic TGCT cell lines, hypersensitivity to therapeutic agents is not associated with p53 status. Next, we examined the impact of p53 inactivation on apoptosis induction in isogeneic NT2 sublines expressing human papillomavirus E6 protein. Evidently, abrogation of p53 function did not affect the hypersensitivity to apoptotic stimuli. We noted that drug-sensitive S2 cells were highly resistant to radiation-induced apoptosis, indicating distinct signalling pathways for chemotherapy and irradiation. The impaired radiation-induced apoptotic pathway in S2 and 2102 EP could not be restored by addition of cell-permeable C2-ceramide, suggesting that the blockade is downstream of ceramide generation. Ligation of Fas/APO-1/CD95 by anti-Fas effectively induced apoptosis in Fas-antigen expressing S2, 2102 EP and 833 KE. The efficient Fas-mediated activation of apoptosis in drug-, radiation-, and ceramide-resistant 2102 EP cells further suggests that diverse apoptosis-inducing factors may use distinct signalling pathways. In summary, we demonstrated the presence of distinct p53-independent apoptotic pathways in TGCT cells.
Insights
Testicular germ cell tumor (TGCT) cells show varied apoptosis responses to stimuli, independent of p53 status. Distinct p53-independent pathways mediate apoptosis, suggesting diverse therapeutic strategies for TGCT.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Testicular germ cell tumors (TGCT) are a significant group of cancers in young men.
- The role of p53 in apoptosis induction and its impact on TGCT treatment remain areas of investigation.
- Understanding apoptosis pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of p53 status in apoptosis induction in TGCT cell lines.
- To explore distinct apoptosis signaling pathways activated by various stimuli in TGCT.
- To determine if p53 inactivation affects sensitivity to apoptotic stimuli in TGCT.
Main Methods:
- Utilized a panel of 6 TGCT cell lines with defined p53 status (wild-type, mutant, or null).
- Exposed cell lines to diverse apoptotic stimuli including cisplatin, doxorubicin, gamma radiation, C2-ceramide, and anti-Fas antibody.
- Assessed apoptosis induction and analyzed p53 functional status and its impact on signaling pathways.
Main Results:
- Apoptosis sensitivity varied among TGCT cell lines but was not consistently associated with p53 status.
- Mutant or null p53 cells and wild-type p53 cells showed differential responses to specific stimuli, indicating p53-independent pathways.
- Drug-sensitive cells exhibited resistance to radiation-induced apoptosis, suggesting distinct signaling mechanisms.
- Fas-mediated apoptosis was effective even in cells resistant to other stimuli, highlighting pathway diversity.
Conclusions:
- p53 status does not appear to be the primary determinant of apoptosis induction in this panel of TGCT cell lines.
- TGCT cells possess distinct, p53-independent apoptotic pathways that respond differently to various stimuli.
- These findings suggest that therapeutic strategies targeting TGCT may need to consider these diverse apoptotic pathways.